MAFIX | MBXIX | MAFIX / MBXIX | |
Total Expense Ratio | 1.79 | 2.03 | 88% |
Annual Report Gross Expense Ratio | 1.87 | 2.03 | 92% |
Fund Existence | 7 years | 9 years | - |
Gain YTD | -8.305 | -1.984 | 419% |
Front Load | N/A | N/A | - |
Min. Initial Investment | 1000000 | 2500 | 40,000% |
Min. Initial Investment IRA | N/A | N/A | - |
Net Assets | 925M | 8.05B | 11% |
Annual Yield % from dividends | 1.69 | 1.92 | 88% |
Returns for 1 year | -12.59 | -0.35 | 3,626% |
Returns for 3 years | -4.87 | 6.92 | -70% |
Returns for 5 years | 15.80 | 52.96 | 30% |
Returns for 10 years | N/A | N/A | - |
1 Day | |||
---|---|---|---|
MFs / NAME | Price $ | Chg $ | Chg % |
MSACX | 18.97 | N/A | N/A |
Morgan Stanley Inst Passport ovrs eq I | |||
SBHIX | 22.84 | N/A | N/A |
Saratoga Health & Biotechnology I | |||
GSMYX | 23.03 | N/A | N/A |
Goldman Sachs Small/Mid Cap Growth Instl | |||
JLCFX | 69.60 | N/A | N/A |
JHancock Fundamental Large Cap Core R4 | |||
WSCRX | 33.77 | N/A | N/A |
Allspring Small Company Growth R6 |